CHF

Medical technology back on track

Retrieved on: 
Wednesday, March 13, 2024

The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.

Key Points: 
  • The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.
  • “We also anticipate a big boost in growth from the increasing use of artificial intelligence in the medical technology and healthcare services industries,” Stefan Blum adds.
  • These were generally characterized by strong growth momentum in surgical procedures and an optimistic outlook for the 2024 fiscal year,” Marcel Fritsch comments.
  • Elevance, which is focused on employer-sponsored health insurance plans, reported better-than-expected profits thanks to a drop in medical costs and an increase in management’s earnings guidance for 2024.

Planned merger of Ina Invest Holding Ltd. and Ina Invest Ltd.

Retrieved on: 
Wednesday, March 13, 2024

Planned merger of Ina Invest Holding Ltd. and Ina Invest Ltd.

Key Points: 
  • Planned merger of Ina Invest Holding Ltd. and Ina Invest Ltd.
    Ina Invest’s Board of Directors asks AGM to approve merger of Ina Invest Holding Ltd. and Ina Invest Ltd. | Simplification of corporate structure | Implenia Ltd.’s stake remains unchanged
    Glattpark (Opfikon), 26 February 2024 – The Board of Directors of Ina Invest Holding Ltd. will propose to the Annual General Meeting on 3 April 2024 to merge the subsidiary Ina Invest Ltd. with the listed Ina Invest Holding Ltd. (up-stream merger).
  • Following the merger, Implenia Ltd. and the public shareholders will hold all shares in the listed Ina Invest Holding Ltd. directly.
  • Implenia previously held a minority stake of 42.5% in the subsidiary Ina Invest Ltd. and will in future hold a stake of around 40% in Ina Invest Holding Ltd.
    Implenia will continue to hold its strategic stake, work closely with Ina Invest and drive the development of its real estate portfolio.
  • The articles of association of Ina Invest Holding Ltd. are being adapted accordingly.

Vencora acquires CREALOGIX

Retrieved on: 
Wednesday, March 13, 2024

TORONTO, ONTARIO AND ZURICH, SWITZERLAND, FEBRUARY 22, 2024 – VENCORA UK LIMITED (“Vencora”) today announced the settlement of its public tender offer (“Offer”) for all publicly held registered shares of CREALOGIX Holding AG (“CREALOGIX”) with a nominal value of CHF 8.00 each.

Key Points: 
  • TORONTO, ONTARIO AND ZURICH, SWITZERLAND, FEBRUARY 22, 2024 – VENCORA UK LIMITED (“Vencora”) today announced the settlement of its public tender offer (“Offer”) for all publicly held registered shares of CREALOGIX Holding AG (“CREALOGIX”) with a nominal value of CHF 8.00 each.
  • CREALOGIX is recognized as a Swiss Fintech 100 company, and its solution set includes CREALOGIX Conversational AI, CREALOGIX Funding Portal and CREALOGIX Lending Origination Hub.
  • “We are incredibly excited to have CREALOGIX become part of Vencora,” said Ateet Patel, Banking Portfolio Manager at Vencora.
  • Following the settlement, Vencora directly and indirectly holds 1,391,622 CREALOGIX shares in aggregate, representing 99.07% of the issued share capital and voting rights of CREALOGIX.

Implenia wins new strategic contracts for building construction and civil engineering

Retrieved on: 
Wednesday, March 13, 2024

Civil engineering work has already started and Green will deliver the first data centre capacity in summer 2025.

Key Points: 
  • Civil engineering work has already started and Green will deliver the first data centre capacity in summer 2025.
  • Implenia has already built the first of three data centres for Green in Dielsdorf and is currently constructing the associated office building on the Green Metro Campus site.
  • Implenia has been commissioned by a pension fund to realise a residential development in the canton of Zurich as total contractor.
  • The Swedish Transport Authority has awarded Implenia the contract for planning and building the Ersmark tunnel in northern Sweden.

Swiss real estate company Amagvik AG starts trading in the SME Main Market of BX Swiss

Retrieved on: 
Wednesday, March 13, 2024

Today, the shares of real estate company Amagvik AG (Ticker: AMAN) are traded for the first time on Swiss Exchange BX Swiss.

Key Points: 
  • Today, the shares of real estate company Amagvik AG (Ticker: AMAN) are traded for the first time on Swiss Exchange BX Swiss.
  • As of today, February 28th 2024, the shares of Amagvik AG are traded on BX Swiss (ISIN: CH1307959705 | Valor: 130795970 | Ticker: AMAN).
  • "The listing of Amagvik AG on BX Swiss is an important step in the dynamic development of our company.
  • "We are pleased to welcome Amagvik AG to BX Swiss and to include them in our main exchange segment, the SME Main Market", says Matthias Müller, CCO of BX Swiss AG.

Research Dynamics: Report on CPH: FY2023 earnings update

Retrieved on: 
Wednesday, March 13, 2024

This report is published by Research Dynamics, an independent research boutique

Key Points: 
  • This report is published by Research Dynamics, an independent research boutique
    In FY2023, the CPH Group (CPH) achieved net sales of CHF 624.0 mn, corresponding to a 14.0% decrease year-on-year (YoY), or -10.4% when adjusted for currency impacts.
  • In October 2023, CPH Group utilized its existing cash balances to fully settle its CHF 100.0 mn corporate bond upon maturity.
  • In FY2023, CPH invested CHF 35.0 mn in fixed assets to boost capacities in its Chemistry and Packaging divisions and improve efficiency across all three divisions.
  • Despite the industry demand down by 21.0% in newsprint and -24% in magazine papers in FY2023, the CPH sold 371,000 tonnes of paper in 2023.

Helvetica Swiss Living Fund experiences rising tenant demand in financial year 2023: suburban locations reduce rent default rate

Retrieved on: 
Wednesday, March 13, 2024

Zurich, 5 March 2024 – The Helvetica Swiss Living Fund (HSL Fund) has closed financial year 2023 with a stable result compared to the previous year.

Key Points: 
  • Zurich, 5 March 2024 – The Helvetica Swiss Living Fund (HSL Fund) has closed financial year 2023 with a stable result compared to the previous year.
  • The rent default rate was reduced to 5.3%, partly thanks to the negotiating skills of Helvetica’s Asset Management team.
  • The increasing attractiveness of the suburban locations due to the high demand for housing, coupled with a decline in construction activity, supports the fund’s investment strategy.
  • For more details, facts and figures, see the 2023 Annual Report of the HSL Fund: https://www.helvetica.com/en/products/download-center

EQS-News: beaconsmind AG: NuWays continues to rate beaconsmind share as 'Buy' – Price target EUR 15.00 

Retrieved on: 
Wednesday, March 13, 2024

February 2024 – Nuways has reviewed its rating of beaconsmind Group (ISIN: CH0451123589 - Ticker: MLBMD), a leading provider of SaaS and IT infrastructure systems focusing on digital transformation, location-based marketing, and WLAN solutions.

Key Points: 
  • February 2024 – Nuways has reviewed its rating of beaconsmind Group (ISIN: CH0451123589 - Ticker: MLBMD), a leading provider of SaaS and IT infrastructure systems focusing on digital transformation, location-based marketing, and WLAN solutions.
  • The rating of the beaconsmind share remains "Buy" with a price target of EUR 15.00 (increased from EUR 13.00).
  • With the current price target, NuWays sees even further upside potential from the current target price stemming from future M&A activities currently not reflected in the target price of EUR 15.00.
  • The current report by NuWays on beaconsmind is available for download on the corporate website of beaconsmind www.beaconsmind.com in the "Investor Relations" section.

REMSleep Holdings Shareholder Update

Retrieved on: 
Monday, March 4, 2024

CLEARWATER, FL, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTC PINK: RMSL) gives an update on FDA process and REMSleep status.

Key Points: 
  • CLEARWATER, FL, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTC PINK: RMSL) gives an update on FDA process and REMSleep status.
  • We have had numerous inquiries asking for REMSleep regulatory status update.
  • REMSleep consultants are confident we will receive our 510(K) and we will never give up until we are successful.
  • REMSleep has addressed this problem by developing a novel CPAP nasal pillow interface that has been engineered to reduce pressure and enable better airflow.

Vencora acquires CREALOGIX

Retrieved on: 
Thursday, February 22, 2024

TORONTO and ZURICH, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- VENCORA UK LIMITED (“Vencora”) today announced the settlement of its public tender offer (“Offer”) for all publicly held registered shares of CREALOGIX Holding AG (“CREALOGIX”) with a nominal value of CHF 8.00 each.

Key Points: 
  • TORONTO and ZURICH, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- VENCORA UK LIMITED (“Vencora”) today announced the settlement of its public tender offer (“Offer”) for all publicly held registered shares of CREALOGIX Holding AG (“CREALOGIX”) with a nominal value of CHF 8.00 each.
  • CREALOGIX is recognized as a Swiss Fintech 100 company, and its solution set includes CREALOGIX Conversational AI, CREALOGIX Funding Portal and CREALOGIX Lending Origination Hub.
  • “We are incredibly excited to have CREALOGIX become part of Vencora,” said Ateet Patel, Banking Portfolio Manager at Vencora.
  • Following the settlement, Vencora directly and indirectly holds 1,391,622 CREALOGIX shares in aggregate, representing 99.07% of the issued share capital and voting rights of CREALOGIX.